TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.44
Delayed Data
As of Mar 30
 -0.01 / -0.69%
Today’s Change
0.82
Today|||52-Week Range
3.88
+44.17%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for TCR2 Therapeutics Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.68. The median estimate represents a +38.89% increase from the last price of 1.44.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in TCR2 Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.78
Sales
$0.00
Reporting Date
May 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 50.11%
 
 
 
 
 
 
Growthannually 46.22%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.